{"id":845,"date":"2020-04-14T11:28:20","date_gmt":"2020-04-14T09:28:20","guid":{"rendered":"https:\/\/www.naogen-pharma.com\/?page_id=845"},"modified":"2020-06-10T17:02:45","modified_gmt":"2020-06-10T15:02:45","slug":"sylvain-fanier-president","status":"publish","type":"page","link":"https:\/\/www.naogen-pharma.com\/en\/management-team\/sylvain-fanier-president\/","title":{"rendered":"Sylvain Fanier, MSc. EMBA, President"},"content":{"rendered":"<p>Sylvain Fanier has devoted his career to overseeing and leading the development of several global medical innovations in the health sector. He\u00a0brings to the company his leadership in strategy, a global perspective of business and financing, acquired over the past 30 years in large groups\u00a0such as Johnson and Johnson and CR Bard and in medical startups. Specializing in breakthrough medical innovation, he has supported the\u00a0success of innovative companies such as Lemerpax, Cardioinsight, Sonoscanner, Soundbite Medical Solutions, Surgivisio and Med-Innov\u00a0through his consulting company, Novariver.<br \/>\nHe obtained a bachelor degree in biochemistry and a master\u2019s degree in biology option physiology at Paul Sabatier University, Toulouse. He\u00a0also holds an EMBA from ESSEC, Paris, France.<br \/>\nSylvain is a director of the board of Soundbite Medical Solutions Inc. (Montreal, Canada), and Surgivisio SAS (Grenoble, France).<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sylvain Fanier has devoted his career to overseeing and leading the development of several global medical innovations in the health sector. He\u00a0brings to the company his leadership in strategy, a&#8230;<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":538,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-845","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.naogen-pharma.com\/en\/wp-json\/wp\/v2\/pages\/845","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.naogen-pharma.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.naogen-pharma.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.naogen-pharma.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.naogen-pharma.com\/en\/wp-json\/wp\/v2\/comments?post=845"}],"version-history":[{"count":5,"href":"https:\/\/www.naogen-pharma.com\/en\/wp-json\/wp\/v2\/pages\/845\/revisions"}],"predecessor-version":[{"id":900,"href":"https:\/\/www.naogen-pharma.com\/en\/wp-json\/wp\/v2\/pages\/845\/revisions\/900"}],"up":[{"embeddable":true,"href":"https:\/\/www.naogen-pharma.com\/en\/wp-json\/wp\/v2\/pages\/538"}],"wp:attachment":[{"href":"https:\/\/www.naogen-pharma.com\/en\/wp-json\/wp\/v2\/media?parent=845"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}